Radiology services company Radiologix will be on its own for a while. Its planned merger with Saunders Karp & Megrue (SKM), a bank specializing in private investments, has been canceled by SKM. Radiologix, which will remain a publicly traded company,
Radiology services company Radiologix will be on its own for a while. Its planned merger with Saunders Karp & Megrue (SKM), a bank specializing in private investments, has been canceled by SKM. Radiologix, which will remain a publicly traded company, derives most of its revenue from diagnostic imaging procedures conducted at 124 physician-owned or -operated imaging centers located in 18 states and the District of Columbia.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.